Can capsaicin (Capsasin) cream be applied to broken or open skin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Capsaicin Cream Should NOT Be Applied to Broken or Open Skin

Do not apply capsaicin cream to broken, damaged, or open skin—this is explicitly contraindicated by FDA labeling and poses risks of excessive irritation, cytotoxicity, and impaired wound healing. 1

FDA-Mandated Contraindications

The FDA drug label for capsaicin (Capsasin) cream clearly states: "do not apply to wounds or to damaged or very sensitive skin" 1. This is a direct warning that must be followed in clinical practice, as the product is approved for external use only on intact skin 1.

Evidence Supporting This Contraindication

Cytotoxic Effects on Wound Healing

  • Capsaicin demonstrates significant cytotoxicity to keratinocytes and fibroblasts, the essential cells for wound healing 2
  • In vitro studies show keratinocyte growth is reduced by 21-31% at commercial concentrations (0.025%-0.20%) 2
  • Fibroblast viability decreases by 30% after 24 hours of capsaicin exposure across all tested concentrations 2
  • At concentrations ≥0.1%, capsaicin penetrates deeper tissue layers, causing degeneration not only at the surface but also in inner layers 2
  • Based on these cytotoxic effects and detrimental impact on wound healing, capsaicin is not indicated for treatment of burns or open wounds 2

Mechanism of Action on Intact Skin

When applied to intact skin only, capsaicin works by:

  • Depleting substance P from sensory nerve fibers through repeated applications 3
  • Causing initial burning/stinging sensations that diminish over 2-4 weeks of continuous use 3
  • Requiring 2-4 weeks of regular application before therapeutic effects are experienced 3

Clinical Applications (Intact Skin Only)

Capsaicin is recommended for use on intact skin in several conditions:

  • Osteoarthritis pain (knee): Moderate evidence supports 0.025%-0.075% capsaicin for pain reduction 3
  • Erythromelalgia: May help control skin pain through receptor desensitization, though evidence is limited 4
  • Neuropathic pain syndromes: Postherpetic neuralgia, diabetic neuropathy, and surgical neuropathic pain show benefit 5, 6, 7
  • Hand osteoarthritis: Effective but associated with frequent local adverse effects (burning/stinging) 8, 9

Critical Safety Warnings

Application Precautions

  • Avoid contact with eyes and mucous membranes 1
  • Do not use at least 1 hour before or immediately after bathing/showering 1
  • Do not bandage tightly or use with heating pads 1
  • Wash hands with soap and water after applying 1

When to Stop Use

Discontinue capsaicin and consult a physician if: 1

  • Condition worsens
  • Excessive redness, irritation, burning, or skin discomfort develops
  • Symptoms persist >7 days or recur after clearing

Common Pitfalls to Avoid

  1. Never apply to abraded, broken, or inflamed skin—this violates FDA labeling and risks severe local reactions and impaired healing 1, 2
  2. Do not expect immediate relief—therapeutic effects require 2-4 weeks of continuous application 3
  3. Warn patients about initial burning—this is expected and typically diminishes with continued use 3, 6
  4. Avoid use in generalized pruritus of unknown origin—evidence does not support efficacy in this context 10

References

Research

Toxic effects of capsaicin on keratinocytes and fibroblasts.

The Journal of burn care & rehabilitation, 1998

Research

Topical capsaicin in dermatologic and peripheral pain disorders.

DICP : the annals of pharmacotherapy, 1991

Research

Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.